Fox Chase Cancer Center

01/13/2026 | Press release | Distributed by Public on 01/13/2026 14:15

A Natural “Safety Switch” Protects the Liver as it Heals from Injury, Study Finds

January 13, 2026
Assistant Professor in the Cancer Signaling and Microenvironment Research Program at Fox Chase Cancer Center
  • Researchers discovered a natural mechanism that helps protect the liver from cancer while it repairs itself.
  • During stress, some liver cells temporarily stop dividing and become resistant to turning cancerous.
  • The findings may lead to new approaches that support liver healing while lowering cancer risk in chronic liver disease.

PHILADELPHIA (January 13, 2026) - New research from scientists at Fox Chase Cancer Center has uncovered a natural "safety switch" in the liver that helps prevent cancer from developing while the organ repairs itself after injury.

The study, published in Nature Communications, shows that liver cells can temporarily pause their growth during times of stress, reducing the risk that rapid regeneration could turn into cancer. The findings shed new light on how the liver balances healing with long-term protection against liver cancer.

"This research gives us a clearer picture of how the liver protects itself. Understanding that process may help us design safer, more effective treatments for liver disease," said Joan Font-Burgada, PhD, senior author on the paper and an Assistant Professor in the Cancer Signaling and Microenvironment Research Programat Fox Chase.

When Healing Becomes Risky

The liver is well known for its ability to regenerate after injury caused by disease, surgery, or toxins. But in chronic liver conditions, where damage happens over and over, this constant regeneration can increase the risk of cancer. Until now, scientists did not fully understand how the liver manages this risk.

The researchers discovered that during liver injury, many liver cells enter a flexible, in-between state rather than fully changing into another cell type. In this temporary state, the cells stop dividing and become highly resistant to turning cancerous.

"These cells act like a built-in safety valve," said Lauren S. Strathearn, PhD, a former postdoctoral fellow in the Font-Burgada lab and a lead author on the study. "They allow the liver to recover from injury while preventing uncontrolled cell growth that could lead to cancer."

How the Liver Knows When to Grow - or Rest

The team found that this protective pause is controlled by a signaling system called Notch, which helps cells sense their environment. When Notch signals are carefully balanced, liver cells know whether to grow or rest, allowing regeneration to happen safely.

To study this process, researchers created a specialized mouse model that allowed them to track these "paused" cells during liver repair. Even when exposed to strong growth signals or cancer-causing mutations, these cells did not form tumors, unlike other liver cells that continued to divide.

What This Means for Future Treatments

The findings help explain why liver regeneration does not automatically lead to cancer and may open the door to new treatments.

In the future, researchers plan to study whether this same protective mechanism works in people with chronic liver diseases such as metabolic liver disease or viral hepatitis. If confirmed, therapies could be developed to activate or enhance this natural defense system, helping the liver heal while lowering cancer risk.

The study, "Plastic Hepatocyte States Limit Liver Cancer Development," was published in Nature Communications.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation's first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center's nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427

Fox Chase Cancer Center published this content on January 13, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on January 13, 2026 at 20:15 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]